Why a Melanoma Vaccine Breakthrough Matters for Synovial Sarcoma

Merck and Moderna are making headlines after their personalized mRNA cancer vaccine entered Phase 3 clinical trials for melanoma. For…

A New CAR-T Cell Approach for Synovial Sarcoma That Does Not Require HLA Matching

A new preclinical study published in Biomedicine and Pharmacotherapy by Tomohiro Miyazaki, Yudai Murayama, Naoki Oike, and colleagues from the…

In Conversation with Kaela: How Research Gave a Mom of Two a Second Chance at Life

Kaela Graham-Bowman’s story reached national audiences this year when she was featured on 60 Minutes Australia. An Afghanistan veteran and…

World’s First MAGE-A4-Targeting TCR-NK Therapy Zelluna Doses First Patient in Clinical Trial

Zelluna ASA, a Norwegian biotech company pioneering allogeneic cell therapies for solid cancers, recently announced that the first patient has…

When Synovial Sarcoma Mimics the Heart’s Most Common Tumor

A case report in AME Case Reports by Yun Xiao, Zhourui Liu, and Sha Li of the Department of Ultrasound…

Closing the AYA Gap: Clinical Trials, Genetic Testing, and Palliative Care for Young Sarcoma Patients

A new educational review in the American Society of Clinical Oncology Educational Book, authored by Sophie Jessop, MBBS, and colleagues,…

Then and Now: Decoding the Chromatin Machinery Behind Synovial Sarcoma

A new profile by Mariella Bodemeier Loayza Careaga, PhD, published in The Scientist, revisits biochemist Cigall Kadoch’s research nearly a…

Synovial Sarcoma Foundation Funds New Data Staff Scientist Position at CHOP

The Synovial Sarcoma Foundation is excited to announce that we have funded a new Data Staff Scientist position at Children’s…